Table 2 Distribution of breast cancer molecular subtypes by age and gender
| Â | Total Tissue Cases (N = 203) | Luminal A (N = 90) | Luminal B (N = 50) | HER+/ER- (N = 24) | Unclassified (N = 16) | Basal-like[CK5/6] (N = 23) | p-value |
|---|---|---|---|---|---|---|---|
| Â | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | Â |
Percent of Tissue Cases | 100.0% | 44.3% | 24.6% | 11.8% | 7.9% | 11.3% | Â |
Sex | Â | Â | Â | Â | Â | Â | Â |
   Female | 198 (97.5%) | 89 (98.9%) | 48 (96.0%) | 23 (95.8%) | 16 (100.0%) | 2 (95.7%) |  |
   Male | 5 (2.5%) | 1 (1.1%) | 2 (4.0%) | 1 (4.2%) | 0 (0.0%) | 1 (4.3%) |  |
Age, years | Â | Â | Â | Â | Â | Â | Â |
   < 30 | 5 (2.9%) | 0 (0.0%) | 3 (7.0%) | 1 (4.5%) | 0 (0.0%) | 1 (5.0%) |  |
   30-40 | 23 (13.4%) | 11 (14.3%) | 5 (11.6%) | 3 (13.6%) | 0 (0.0%) | 4 (20.0%) |  |
   41-50 | 64 (37.2%) | 25 (32.5%) | 22 (51.2%) | 7 (31.8%) | 2 (20.0%) | 8 (40.0%) |  |
   30-50 | 87 (50.6%) | 36 (46.8%) | 27 (62.8%) | 10 (45.5%) | 2 (20.0%) | 12 (60.0%) |  |
   > 50 | 80 (46.5%) | 41 (53.2%) | 13 (30.2%) | 11 (50.0%) | 8 (80.0%) | 7 (35.0%) |  |
   Not Available | 31 | 13 | 7 | 2.00 | 6.00 | 3.00 |  |
   Mean | 51.30 | 52.31 | 48.19 | 51.64 | 57.10 | 50.05 | 0.138 |
   Median | 50.00 | 52.00 | 48.00 | 52.50 | 58.00 | 46.50 |  |
   SD | 10.78 | 9.66 | 11.50 | 12.20 | 7.56 | 12.79 |  |
   Mean from Cairo | 53.4 | 55.45 | 48.84 | 53.40 | 57.10 | 49.29 |  |
   Mean from Minia | 49.46 | 49.95 | 47.67 | 50.38 |  | 50.46 |  |
   Age Range | 24 - 80 | 30 - 73 | 25 - 80 | 24 - 77 | 42 - 70 | 28 - 80 |  |
   Age Range from Cairo | 25 - 73 | 35 - 73 | 25 - 65 | 38 - 72 | 42 - 70 | 28 - 70 |  |
   Age Range from Minia | 24 - 80 | 30 - 70 | 25 - 80 | 24 - 77 |  | 40 - 80 |  |